Feature | Cath Lab | September 14, 2016

VIVA Announces Late-Breaking Clinical Trial Presentations

VIVA 2016, late breaking trials, cath lab

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular interventions. All trials represent data never before presented and are of global significance to physicians and others interested in the rapid advancement of therapies for vascular diseases. The meeting is Sept. 18-22, in Las Vegas, Nev.

Presentations Monday, Sept. 19 

8:31 AM — MOBILE Clinical Trial: MarrOwStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD) — Michael P. Murphy, M.D., FACS

8:43 AM — Safety and Performance of the Shockwave Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: Six-Month Results from the Two-phase DISRUPT PAD Study — Thomas Zeller, M.D.

8:55 AM — Results from the IN.PACT SFA Randomized Trial — Prakash Krishnan, M.D.

9:07 AM — VIRTUS US Iliofemoral Stenting IDE Trial  — Stephen Black, M.D.

9:19 AM — Drug-Coated Balloon Treatment for Patients With Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort — Michael R. Jaff, D.O.   


Presentations Tuesday, Sept. 20 

8:10 AM — Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study — Ali Azizzadeh, M.D.  

8:22 AM — Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry — Zvonimir Krajcer, M.D.      

8:34 AM — Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach — Charmaine Lok, M.D., FRCPC        

8:46 AM — MAJESTIC 2 Year Results Plus Sub-group Analysis —Stefan Müller-Hülsbeck, M.D.

8:59 AM — 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study — Antonio Micari, M.D., Ph.D.    


Presentations Wednesday, Sept. 21

9:10 AM — ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries — Richard Rapoza, M.D.  

9:22 AM — 12 Month Results from the DANCE Trial Atherectomy Cohort — Chris Owens, M.D.      

9:34 AM — Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial 
— John Laird, M.D.

9:44 AM — Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial — Ido Weinberg, M.D.   

9:54 AM — Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial  — John Laird, M.D.   

10:04 AM — PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery  — Richard Saxon, M.D. 


For more information: vivaphysicians.org/annual-conference/viva-16/

Related Content

American College of Cardiology Expands Patient Navigator Program
News | Cath Lab | March 21, 2018
March 21, 2018 — Hundreds of hospitals across the United States will have access to tools and resources to help impro
Videos | Cath Lab | March 15, 2018
A discussion with Hitinder Gurm, M.D., MBBS, FACC, professor, internal medicine, and associate chief clinical officer
News | Cath Lab | February 27, 2018
The American College of Cardiology (ACC) and the Saudi Arabian Cardiac Interventional Society have partnered to...
News | Cath Lab | February 23, 2018
February 23, 2018 — CorFlow Therapeutics AG announced that the company will present new insights into the coronary mi
Teleflex Launches Next-Generation Sympro Elite and Expro Elite Snares
Technology | Cath Lab | February 07, 2018
Teleflex Inc. has announced 510(k) clearance by the U.S. Food and Drug Administration (FDA) and U.S. commercial launch...
SCAI Advocacy Committee Highlights Reimbursement Reform Efforts in 2017
News | Cath Lab | January 30, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) highlighted the efforts of its Advocacy Committee...
IAC Releases Cardiovascular Catheterization Accreditation Program
News | Cath Lab | January 25, 2018
January 25, 2018 – The Intersocietal Accreditation Commission (IAC) announced the release of its Cardiovascular Cathe
Videos | Cath Lab | January 04, 2018
Bernadette Speiser, BSN, MSN, CCRN, RCIS, a cardiac cath/EP nurse at Palo Alto Veterans Hospital, Palo Alto, Calif.,
FDA Initiates Class I Recall of Sterilmed Reprocessed Agilis Steerable Introducer Sheath
News | Cath Lab | January 04, 2018
The U.S. Food and Drug Administration (FDA) announced a Class I recall of Sterilmed’s Agilis Steerable Introducer...
The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA atherectomy system. Athar Ansari, M.D.

The California Heart & Vascular Clinic in El Centro, Calif., treated the first post-FDA clearance patient with a DABRA system. 

Feature | Cath Lab | November 24, 2017 | Athar Ansari, M.D., FACC
As debates about the current state and future of healthcare rage in Congress, the media and healthcare settings acros
Overlay Init